We Are Leading Manufacture & Suppliers Of Pharmaceutical Equipment Srinivasa.
African pharmaceutical manufacture myth or reality presentation
-
Upload
the-scinnovent-centre -
Category
Technology
-
view
404 -
download
9
description
Transcript of African pharmaceutical manufacture myth or reality presentation
![Page 1: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/1.jpg)
![Page 2: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/2.jpg)
![Page 3: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/3.jpg)
![Page 4: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/4.jpg)
Source: GIZ (2011) EAC pharmaceutical manufacturing survey
![Page 5: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/5.jpg)
![Page 6: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/6.jpg)
![Page 7: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/7.jpg)
Why the increased interest in African Pharma?
Estimated IFC (2009)~US$3.8 billion by 2016, others forecast US$ 23 billion by 2020
Local manufacturers account for Only 25–30%
Population Current: 1.033 billion
Estimated: 1.3 billion by 2020
![Page 8: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/8.jpg)
![Page 9: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/9.jpg)
http://www.strategyand.pwc.com/media/file/Strategyand_Pharma-Emerging-Markets-2.0.pdf
![Page 10: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/10.jpg)
![Page 11: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/11.jpg)
Increasingly there is purposive engagement to influence policy.
However power and influence over policy and direction:
Global Health Players/Institutions » Continental » Regional »Local institutions!!!
![Page 12: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/12.jpg)
R&D; Reformulation
Global Health Systems
Local Health Sytem Financing
![Page 13: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/13.jpg)
Procurement as an Asset: Mackintosh and Chataway (2013) – Personal Communication
![Page 14: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/14.jpg)
![Page 15: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/15.jpg)
Reductions and Increase
Country 2001 2011 Mozambique 14.8% 7.8%
Chad 13.8% 3.3%
DRC 2.8% 10.8%
Achievers
Country 2011 Rwanda 23.8%
Liberia 18.9%
Malawi 18.5%
Zambia 16.0%
Togo 15.4%
Madagascar 15.3%
Nearly There…….
Country 2011 Swaziland 14.9%
Ethiopia 14.6%
Lesotho 14.6%
Djibouti 14.2%
https://www.devex.com/news/health-funding-in-africa-how-close-is-the-au-to-meeting-abuja-targets-81567 accessed 22/04/2014
MNCs see African pharmaceutical markets as a long
term opportunity because of lack of assured public
health financing
If public health funding is resolved then local
manufacturers will face intense competition from
mature market players seeking new avenues for
revenue and profit growth
![Page 16: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/16.jpg)
Source: Banda (2013). Finance as a forgotten technological capability for promoting African local pharmaceutical
manufacture in Africa. International Journal of Technology Management and Sustainable Development. 12 (2)
![Page 17: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/17.jpg)
Source: Banda (2013). Finance as a forgotten technological capability for promoting African local pharmaceutical
manufacture in Africa. International Journal of Technology Management and Sustainable Development. 12 (2)
![Page 18: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/18.jpg)
![Page 19: African pharmaceutical manufacture myth or reality presentation](https://reader034.fdocuments.in/reader034/viewer/2022042814/55577bacd8b42ace7f8b5736/html5/thumbnails/19.jpg)